Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Receivables (2023 - 2024)

Historic Receivables for AC Immune (ACIU) over the last 2 years, with Q4 2024 value amounting to $1.3 million.

  • AC Immune's Receivables fell 9999.24% to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year decrease of 9999.24%. This contributed to the annual value of $1.3 million for FY2024, which is 9999.24% down from last year.
  • According to the latest figures from Q4 2024, AC Immune's Receivables is $1.3 million, which was down 9999.24% from $29.4 million recorded in Q3 2024.
  • AC Immune's 5-year Receivables high stood at $16.7 billion for Q4 2023, and its period low was $1.3 million during Q4 2024.